Bilaketaren emaitzak - Z. Szijgyarto

  • Erakusten 1 - 1 emaitzak -- 1
Findu emaitzak
  1. 1
    57O Randomized double-blind phase II trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC: Primary results

    57O Randomized double-blind phase II trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC: Primary results nork Solange Peters, S.M. Lim, A.L. Ortega Granados, G.D.J. Pinto, C.S. Fuentes, G. Lo Russo, M. Schenker, J.S. Ahn, M. Reck, Z. Szijgyarto, N. Huseinovic, E. Zografos, S. O’Donnell, F. de Marinis

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: